Europe

Switzerland

To further support the growing number of pharmaceutical companies investing in microbials, Lonza, a Swiss multinational chemicals and biotechnology company, is expanding its microbial development laboratories by 50%


More lines about Switzerland, Europe

Visit all Switzerland lines archive